Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Myelofibrosis")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 898

  • Page / 36
Export

Selection :

  • and

Modern management of myelofibrosisCERVANTES, Francisco.British journal of haematology. 2005, Vol 128, Num 5, pp 583-592, issn 0007-1048, 10 p.Article

Myelofibrosis with myeloid metaplasia: New developments in pathogenesis and treatmentDINGLI, David; MESA, Ruben A; TEFFERI, Ayalew et al.Internal medicine (Tokyo. 1992). 2004, Vol 43, Num 7, pp 540-547, issn 0918-2918, 8 p.Article

New approaches in the treatment of myelofibrosisHENNESSY, Bryan T; THOMAS, Deborah A; GILES, Francis J et al.Cancer. 2005, Vol 103, Num 1, pp 32-43, issn 0008-543X, 12 p.Article

ANALYSIS OF THE ANDROGEN RESPONSE OF 23 PATIENTS WITH AGNOGENIC MYELOID METAPLASIA. THE VALUE OF CHROMOSOMAL STUDIES IN PREDICTING RESPONSE AND SURVIVALBESA EC; NOWELL PC; GELLER NL et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 49; NO 2; PP. 308-313; BIBL. 29 REF.Article

Erythropoietin treatment of the anaemia of myelofibrosis with myeloid metaplasia: results in 20 patients and review of the literatureCERVANTES, Francisco; ALVAREZ-LARRAN, Alberto; HERNANDEZ-BOLUDA, Juan-Carlos et al.British journal of haematology. 2004, Vol 127, Num 4, pp 399-403, issn 0007-1048, 5 p.Article

ASXL1 mutations in primary and secondary myelofibrosisRICCI, Clara; SPINELLI, Orietta; SALMOIRAGHI, Silvia et al.British journal of haematology. 2012, Vol 156, Num 3, pp 404-407, issn 0007-1048, 4 p.Article

Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasiaARORA, Brijesh; HO, Ching-Liang; HOYER, James D et al.Haematologica (Roma). 2004, Vol 89, Num 12, pp 1454-1458, issn 0390-6078, 5 p.Article

Darbepoetin-alpha for the anaemia of myelofibrosis with myeloid metaplasiaCERVANTES, Francisco; ALVAREZ-LARRAN, Alberto; HERNANDEZ-BOLUDA, Juan-Carlos et al.British journal of haematology. 2006, Vol 134, Num 2, pp 184-186, issn 0007-1048, 3 p.Article

Conventional and new treatment options for myelofibrosis with myeloid metaplasiaODENIKE, Olatoyosi; TEFFERI, Ayalew.Seminars in oncology. 2005, Vol 32, Num 4, pp 422-431, issn 0093-7754, 10 p.Article

The spleen in myelofibrosis with myeloid metaplasiaTEFFERI, Ayalew; NAGORNEY, David M.Mayo Clinic proceedings. 2004, Vol 79, Num 4, issn 0025-6196, p. 503Article

How I treat myelofibrosisTEFFERI, Ayalew.Blood. 2011, Vol 117, Num 13, pp 3494-3504, issn 0006-4971, 11 p.Article

Splénomégalie myéloïde = Myelofibrosis with myeloid metaplasiaHématologie (Montrouge). 2007, Vol 13, Num 5, pp 335-337, issn 1264-7527, 3 p.Article

Phase1/-2 study of pomalidomide in myelofibrosisMESA, Ruben A; PARDANANI, Animesh D; HUSSEIN, Kebede et al.American journal of hematology. 2010, Vol 85, Num 2, pp 129-130, issn 0361-8609, 2 p.Article

How I treat symptomatic splenomegaly in patients with myelofibrosisMESA, Ruben A.Blood. 2009, Vol 113, Num 22, pp 5394-5400, issn 0006-4971, 7 p.Article

Pathogenesis of myelofibrosis with myeloid metaplasiaTEFFERI, Ayalew.Journal of clinical oncology. 2005, Vol 23, Num 33, pp 8520-8530, issn 0732-183X, 11 p.Article

Myelofibrosis: an update on current pharmacotherapy and future directionsCERVANTES, Francisco; MARTINEZ-TRILLOS, Alejandra.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 7, pp 873-884, issn 1465-6566, 12 p.Article

How to manage polycythemia veraPASSAMONTI, F.Leukemia. 2012, Vol 26, Num 5, pp 870-874, issn 0887-6924, 5 p.Article

Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypesSTEIN, Brady L; WILLIAMS, Donna M; O'KEEFE, Christine et al.Haematologica (Roma). 2011, Vol 96, Num 10, pp 1462-1469, issn 0390-6078, 8 p.Article

Bone marrow fibrosis : pathophysiology and clinical significance of increased bone marrow stromal fibresKUTER, David J; BAIN, Barbara; MUFTI, Ghulam et al.British journal of haematology. 2007, Vol 139, Num 3, pp 351-362, issn 0007-1048, 12 p.Article

The burden of fatigue and quality of life in myeloproliferative disorders (MPDs) : An international internet-based survey of 1179 MPD patientsMESA, Ruben A; NIBLACK, Joyce; WADLEIGH, Martha et al.Cancer. 2007, Vol 109, Num 1, pp 68-76, issn 0008-543X, 9 p.Article

Outcome of allogeneic stem cell transplantation in patients with myelofibrosisDITSCHKOWSKI, M; BEELEN, D. W; TRENSCHEL, R et al.Bone marrow transplantation (Basingstoke). 2004, Vol 34, Num 9, pp 807-813, issn 0268-3369, 7 p.Article

ETUDE DES PARAMETRES DE PRONOSTIC DANS LA SPLENOMEGALIE MYELOIDENAJEAN Y; DRESCH C; CACCHIONE R et al.1980; ANN. MED. INTERNE; FRA; DA. 1980; VOL. 131; NO 3; PP. 141-145; ABS. ENG; BIBL. 26 REF.Article

Efficacy and safety of pegylated-interferon α-2a in myelofibrosis: a study by the FIM and GEM French cooperative groupsIANOTTO, Jean-Christophe; BOYER-PERRARD, Françoise; DUPRIEZ, Brigitte et al.British journal of haematology. 2013, Vol 162, Num 6, pp 783-791, issn 0007-1048, 9 p.Article

Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60-78 years of ageSAMUELSON, Scott; SANDMAIER, Brenda M; HESLOP, Helen E et al.British journal of haematology. 2011, Vol 153, Num 1, pp 76-82, issn 0007-1048, 7 p.Article

Incidence of leukaemia in patients with primary myelofibrosis and RBC-transfusion-dependencePASSAMONTI, Francesco; RUMI, Elisa; ELENA, Chiara et al.British journal of haematology. 2010, Vol 150, Num 6, pp 719-721, issn 0007-1048, 3 p.Article

  • Page / 36